27588935|t|One-hour post-load hyperglycemia combined with HbA1c identifies pre-diabetic individuals with a higher cardio-metabolic risk burden
27588935|a|Evidence suggests that combining 1-hour plasma glucose ≥155 mg/dl during an oral glucose tolerance test (OGTT) with glycosylated hemoglobin (HbA1c) significantly increases their predictive power for incident diabetes, while their individual and joint associations with cardio-metabolic risk factors remain undefined. Herein, we evaluated whether 1-hour post-load plasma glucose ≥155 mg/dl combined with HbA1c may identify pre-diabetic individuals with a higher cardio-metabolic risk. Anthropometric and metabolic characteristics, insulin sensitivity and insulin secretion assessed by OGTT -derived indexes, carotid intima-media thickness (IMT), pulse pressure, and rate pressure product were evaluated in 1495 individuals. As compared with subjects with 1-hour post-load glucose <155 mg/dl, individuals with 1-hour post-load glucose ≥155 mg/dl exhibited a significantly worse cardio metabolic profile, both in the group with HbA1c <5.7%, and in the group with prediabetes (HbA1c 5.7-6.4%). Specifically, in both groups, subjects with 1-hour post-load glucose ≥155 mg/dl had higher fasting and 2-h post-load glucose (p < 0.0001 for all in both group s), higher HOMA-IR (p < 0.0001 in both groups), and carotid IMT (p = 0.05 in the group with HbA1c <5.7% and p = 0.03 in the group HbA1c 5.7-6.4%), as well as lower Matsuda index, insulinogenic index and disposition index (p < 0.0001 in both groups), and lower insulin - stimulated glucose disposal (p < 0.0001 in the group with HbA1c <5.7% and p = 0.03 in the group HbA1c 5.7-6.4%). Hyperglycemia at 1-hour during an OGTT may be a useful tool to identify a subset of individuals within HbA1c -defined glycemic categories at higher risk of developing type 2 diabetes and cardiovascular disease.
27588935	0	18	One-hour post-load	T079	C1439504
27588935	19	32	hyperglycemia	T047	C0020456
27588935	47	52	HbA1c	T116,T123	C0019018
27588935	64	76	pre-diabetic	T079	C1254367
27588935	77	88	individuals	T098	C0237401
27588935	103	131	cardio-metabolic risk burden	T201	C2321263
27588935	165	186	1-hour plasma glucose	T201	C0797930
27588935	208	235	oral glucose tolerance test	T060	C0029161
27588935	237	241	OGTT	T060	C0029161
27588935	248	271	glycosylated hemoglobin	T116,T123	C0019018
27588935	273	278	HbA1c	T116,T123	C0019018
27588935	331	339	incident	T067	C1551358
27588935	340	348	diabetes	T047	C0011847
27588935	401	430	cardio-metabolic risk factors	T201	C2321263
27588935	460	469	evaluated	T058	C0220825
27588935	478	509	1-hour post-load plasma glucose	T201	C0797930
27588935	535	540	HbA1c	T116,T123	C0019018
27588935	554	566	pre-diabetic	T079	C1254367
27588935	567	578	individuals	T098	C0237401
27588935	593	614	cardio-metabolic risk	T078	C0035647
27588935	616	630	Anthropometric	T060	C2459906
27588935	635	644	metabolic	T043	C1524026
27588935	645	660	characteristics	T080	C1521970
27588935	662	681	insulin sensitivity	T046	C0920563
27588935	686	703	insulin secretion	T043	C1256369
27588935	716	720	OGTT	T060	C0029161
27588935	730	737	indexes	T170	C0918012
27588935	739	769	carotid intima-media thickness	T201	C1960466
27588935	771	774	IMT	T201	C1960466
27588935	777	791	pulse pressure	T040	C0949236
27588935	797	810	rate pressure	T081	C1442094
27588935	824	833	evaluated	T058	C0220825
27588935	842	853	individuals	T098	C0237401
27588935	886	910	1-hour post-load glucose	T201	C0797930
27588935	923	934	individuals	T098	C0237401
27588935	940	964	1-hour post-load glucose	T201	C0797930
27588935	1008	1032	cardio metabolic profile	T039	C3853758
27588935	1046	1051	group	T098	C1257890
27588935	1057	1062	HbA1c	T116,T123	C0019018
27588935	1081	1086	group	T098	C1257890
27588935	1092	1103	prediabetes	T047	C0362046
27588935	1105	1110	HbA1c	T116,T123	C0019018
27588935	1144	1150	groups	T098	C1257890
27588935	1166	1190	1-hour post-load glucose	T201	C0797930
27588935	1206	1220	higher fasting	T034	C1261430
27588935	1225	1246	2-h post-load glucose	T034	C1318376
27588935	1275	1280	group	T098	C1257890
27588935	1292	1299	HOMA-IR	T059	C3639411
27588935	1320	1326	groups	T098	C1257890
27588935	1333	1344	carotid IMT	T201	C1960466
27588935	1362	1367	group	T098	C1257890
27588935	1373	1378	HbA1c	T116,T123	C0019018
27588935	1405	1410	group	T098	C1257890
27588935	1411	1416	HbA1c	T116,T123	C0019018
27588935	1445	1458	Matsuda index	T170	C0918012
27588935	1460	1479	insulinogenic index	T170	C0918012
27588935	1484	1501	disposition index	T170	C0918012
27588935	1522	1528	groups	T098	C1257890
27588935	1541	1548	insulin	T116,T121,T125	C0021641
27588935	1551	1561	stimulated	T061	C1292856
27588935	1562	1569	glucose	T109,T121,T123	C0017725
27588935	1598	1603	group	T098	C1257890
27588935	1609	1614	HbA1c	T116,T123	C0019018
27588935	1641	1646	group	T098	C1257890
27588935	1647	1652	HbA1c	T116,T123	C0019018
27588935	1664	1677	Hyperglycemia	T047	C0020456
27588935	1698	1702	OGTT	T060	C0029161
27588935	1719	1723	tool	T059	C0022885
27588935	1748	1759	individuals	T098	C0237401
27588935	1767	1772	HbA1c	T116,T123	C0019018
27588935	1782	1801	glycemic categories	T081	C1136206
27588935	1831	1846	type 2 diabetes	T047	C0011860
27588935	1851	1873	cardiovascular disease	T047	C0007222